nok 0
Oppdatert 21.07.2018
Endring % 0,00% Uendret aksjekurs
Endring 0,00 Uendret aksjekurs
Volum 0
Høy NOK 0
Lav NOK 0
Åpen NOK 0
ISIN NO0010000045
For. sluttkurs NOK 0
Ant. aksjer 21,59M
Markedsverdi 0,00M NOK
Intradag

Market closed
Photocure ASA NOK0.5
Markedet er lukket, åpner kl. 09:00
 
Prisutvikling Siste 1 uke 1 mnd. 3 mnd. 6 måneder 1 år
 
  0,00 -100,0% Fallende aksjekurs -100,0% Fallende aksjekurs -100,0% Fallende aksjekurs -100,0% Fallende aksjekurs -100,0% Fallende aksjekurs
Nøkkeltall (mill NOK)
Omsetning
EBIT
Årsresultat
Egenkapital
Balanse
2010
177 357
-
59 015
513 842
513 842
2009
60 080
-
-76 500
456 862
456 862
2008
108 477
-
-64 382
237 848
237 846
2007
106 631
-
-74 969
301 394
301 395
2006
216 010
-
84 731
375 423
375 423
Powered by TradingView

Bedriftsprofil

PhotoCure ASA is a Norway based specialty pharmaceutical company. Its technology platform is focused on the field of photodynamic diagnosis and treatment in the areas of dermatology and cancer. The group has operations in Norway, Sweden, Denmark, Finland and the United States. The operating segments of the group are Commercial franchise and Development portfolio. The company markets product through its commercial operation in the Nordic region under the brand name Hexvix and in the US under the brand name Cysview. It generates prime revenue from the Commercial franchise segment which includes the Hexvix and Cysview products. In addition, the firm also has two device products, Cevira and Visonac, both targeted at indications with medical need and market potential.

Copyright Euroinvestor A/S 2018   Betingelser og vilkår
Kursinformasjon leveres av Morningstar.
Alle kurser er 15-20 minutter forsinket som følge av distribusjonsavtaler satt av de forskjellige børserne.
 
søndag 22. juli 2018 07:13:01
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180712.1 - EUROWEB1 - 2018-07-22 07:13:01 - 2018-07-22 07:13:01 - 8 - Website: OKAY